National Bank of Canada FI Buys 23,164 Shares of Outset Medical, Inc. (NASDAQ:OM)

National Bank of Canada FI boosted its stake in Outset Medical, Inc. (NASDAQ:OM) by 79.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 52,407 shares of the company’s stock after buying an additional 23,164 shares during the quarter. National Bank of Canada FI owned approximately 0.10% of Outset Medical worth $35,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. GSA Capital Partners LLP grew its stake in Outset Medical by 924.7% in the 3rd quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after purchasing an additional 1,003,135 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in Outset Medical by 118.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock worth $5,925,000 after buying an additional 834,663 shares during the last quarter. Millennium Management LLC raised its position in Outset Medical by 58.8% in the second quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after acquiring an additional 719,412 shares during the period. Marshall Wace LLP boosted its stake in Outset Medical by 487.8% in the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock valued at $1,210,000 after acquiring an additional 260,740 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new position in shares of Outset Medical during the 2nd quarter valued at approximately $827,000.

Outset Medical Trading Up 1.0 %

NASDAQ:OM opened at $1.02 on Thursday. Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $6.36. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. The firm’s 50 day moving average is $0.81 and its 200 day moving average is $1.80. The stock has a market capitalization of $53.59 million, a PE ratio of -0.37 and a beta of 2.16.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.